{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:01:14Z","timestamp":1774321274278,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00345-018-2339-y","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T08:54:29Z","timestamp":1526374469000},"page":"1877-1881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A randomized controlled trial evaluating sildenafil citrate in relieving ureteral stent-related symptoms"],"prefix":"10.1007","volume":"36","author":[{"given":"Mohamed","family":"Tharwat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Elsaadany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Lashin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-7306","authenticated-orcid":false,"given":"Ahmed R.","family":"EL-Nahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"2339_CR1","first-page":"522","volume":"31","author":"I Scameciu","year":"2015","unstructured":"Scameciu I, Lupu S, Pricop C, Morbidity SC (2015) Impact on quality of life in patients with indwelling ureteral stents: a 10-year clinical experience. Pak J Med Sci 31:522\u2013526","journal-title":"Pak J Med Sci"},{"key":"2339_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/end.2006.20.33","volume":"20","author":"A El-nahas","year":"2006","unstructured":"El-nahas A, El-assmy A, Shoma A, Eraky I, El-kenawy M, El-kappany H (2006) Self-retaining ureteral stents: analysis of factors responsible for patients\u2019 discomfort. J Endourol 20:33\u201337","journal-title":"J Endourol"},{"key":"2339_CR3","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.juro.2009.02.019","volume":"181","author":"JE Lingeman","year":"2009","unstructured":"Lingeman JE, Preminger GM, Goldfischer ER, Krambeck AE (2009) Assessing the impact of ureteral stent design on patient comfort. J Urol 181:2581\u20132587","journal-title":"J Urol"},{"key":"2339_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.juro.2010.06.043","volume":"184","author":"A Dellis","year":"2010","unstructured":"Dellis A, Joshi HB, Timoney AG, Keeley FX Jr (2010) Relief of stent related symptoms: review of engineering and pharmacological solutions. J Urol 184:1267\u20131272","journal-title":"J Urol"},{"key":"2339_CR5","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1464-410X.2011.10170.x","volume":"108","author":"AD Lamb","year":"2011","unstructured":"Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ (2011) Meta-analysis showing the beneficial effect of \u03b1-blockers on ureteric stent discomfort. BJU Int 108:1894\u20131902","journal-title":"BJU Int"},{"key":"2339_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/end.2014.0715","volume":"29","author":"L Zhou","year":"2015","unstructured":"Zhou L, Cai X, Li H, Wang KJ (2015) Effects of \u03b1-blockers, antimuscarinics, or combination therapy in relieving ureteral stent-related symptoms: a meta-analysis. J Endourol 29:650\u2013656","journal-title":"J Endourol"},{"key":"2339_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/end.2016.0129","volume":"30","author":"C Koprowski","year":"2016","unstructured":"Koprowski C, Kim C, Modi PK, Elsamra SE (2016) Ureteral stent-associated pain: a review. J Endourol 30:744\u2013753","journal-title":"J Endourol"},{"key":"2339_CR8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","volume":"61","author":"M Gacci","year":"2012","unstructured":"Gacci M, Corona G, Salvi M et al (2012) A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61:994\u20131003","journal-title":"Eur Urol"},{"key":"2339_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5527\/wjn.v4.i1.138","volume":"4","author":"LT Zhang","year":"2015","unstructured":"Zhang LT, Park JK (2015) Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia? World J Nephrol 4:138\u2013147","journal-title":"World J Nephrol"},{"key":"2339_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1476-5381.2010.00748.x","volume":"160","author":"S Oger","year":"2010","unstructured":"Oger S, Behr-Roussel D, Gorny D et al (2010) Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle. Br J Pharmacol 160:1135\u20131143","journal-title":"Br J Pharmacol"},{"key":"2339_CR11","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.juro.2007.07.048","volume":"178","author":"M Gacci","year":"2007","unstructured":"Gacci M, del Popolo G, Macchiarella A, Celso M et al (2007) Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. J Urol 178:2040\u20132043","journal-title":"J Urol"},{"key":"2339_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aju.2015.12.001","volume":"14","author":"AA Shokeir","year":"2016","unstructured":"Shokeir AA, Tharwat MA, Abolazm AE, Harraz A (2016) Sildenafil citrate as a medical expulsive therapy for distal ureteric stones: a randomised double-blind placebo-controlled study. Arab J Urol. 14:1\u20136","journal-title":"Arab J Urol."},{"key":"2339_CR13","doi-asserted-by":"publisher","first-page":"592175","DOI":"10.1155\/2015\/592175","volume":"2015","author":"SP Aggarwal","year":"2015","unstructured":"Aggarwal SP, Priyadarshi S, Tomar V (2015) A randomized controlled trial to compare the safety and efficacy of tadalafil and tamsulosin in relieving double J stent related symptoms. Adv Urol 2015:592175","journal-title":"Adv Urol"},{"key":"2339_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.aju.2014.08.001","volume":"12","author":"AR El-Nahas","year":"2014","unstructured":"El-Nahas AR, El-saadony MM, Tharwat M et al (2014) Validation of Arabic linguistic version of ureteral stent symptoms questionnaire. Arab J Urol 12:290\u2013293","journal-title":"Arab J Urol"},{"key":"2339_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1464-410X.2011.10903.x","volume":"110","author":"CE Mendez-Probst","year":"2012","unstructured":"Mendez-Probst CE, Goneau LW, MacDonald KW et al (2012) The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial.\u201d. BJU Int 110:749\u2013754","journal-title":"BJU Int"},{"key":"2339_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.juro.2009.11.035","volume":"183","author":"AE Krambeck","year":"2010","unstructured":"Krambeck AE, Walsh RS, Denstedt JD et al (2010) A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol 183:1037\u20131042","journal-title":"J Urol"},{"key":"2339_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007","unstructured":"McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177:1071\u20131077","journal-title":"J Urol"},{"key":"2339_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1743-6109.2009.01511.x","volume":"7","author":"B Fibbi","year":"2010","unstructured":"Fibbi B, Morelli A, Vignozzi L et al (2010) Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med 7:59\u201369","journal-title":"J Sex Med"},{"key":"2339_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","volume":"63","author":"F Giuliano","year":"2013","unstructured":"Giuliano F, Uckert S, Maggi M, Birder L, Kissel J, Viktrup L (2013) The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Eur Urol 63:506\u2013516","journal-title":"Eur Urol"},{"key":"2339_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00240-006-0073-1","volume":"35","author":"C Gratzke","year":"2007","unstructured":"Gratzke C, \u00dcckert S, Kedia G et al (2007) In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach. Urol Res 35:49\u201354","journal-title":"Urol Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2339-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:57:14Z","timestamp":1557863834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2339"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2339-y","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest. There was no external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}